Day: December 7, 2020

— Results from the multiple–ascending dose trial demonstrate proof-of-concept for SRP-5051 and support continued dose escalation —— At a total dose exposure approximately 10x lower than eteplirsen, SRP-5051 at 20 mgs/kg showed enhanced tissue exposure, greater exon skipping, and greater dystrophin production with no negative renal or other laboratory findings —— These are the first clinical results from the Company’s peptide phosphorodiamidate morpholino oligomer (PPMO) technology, its next-generation chemistry platform —CAMBRIDGE, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced results from the ongoing MOMENTUM study (Study 5051-201), a global Phase 2 clinical trial, of SRP-5051,...

HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) — The board of directors of Apache Corporation (Nasdaq: APA) has declared a regular cash dividend on the company’s common shares.The dividend on common shares is payable Feb. 22, 2021, to stockholders of record on Jan. 22, 2021, at a rate of 2.5 cents per share on the corporation’s common stock.About ApacheApache Corporation is an oil and gas exploration and production company with operations in the United States, Egypt and the United Kingdom and exploration activities offshore Suriname. Apache posts announcements, operational updates, investor information and press releases on its website, www.apachecorp.com. Specific information concerning Suriname, ESG performance and other investor-related topics are posted at investor.apachecorp.com.

NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATON INTO THE UNITED STATESVANCOUVER, British Columbia, Dec. 07, 2020 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is pleased to announce that it has entered into a subscription agreement with Dundee Corporation with respect to the issuance of unsecured convertible debentures (the “Debentures”) of the Company for gross proceeds of US$6.5 million (the “Offering”).The Debentures will mature five years following the closing date with an interest rate of 7% per annum and, subject to certain terms and conditions, will be convertible into up to an aggregate of 11,627,907 common shares of the Company (the “Conversion Shares”) at a conversion price of US$0.559 per Conversion Share (being CDN$0.715 per Conversion Share converted...

BALA CYNWYD, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) — Global Indemnity Group, LLC (NASDAQ:GBLI) (the “Company”) announced today its Board of Directors has approved a distribution payment of $0.25 per common share to be paid on December 31, 2020 to all shareholders of record as of the close of business on December 24, 2020.About Global Indemnity Group, LLC and its subsidiariesGlobal Indemnity Group, LLC (NASDAQ:GBLI), through its several direct and indirect wholly owned subsidiary insurance companies, provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. Global Indemnity Group, LLC’s four primary segments are:Commercial SpecialtySpecialty PropertyFarm, Ranch, & StableReinsuranceFor more information,...

BUFORD, Ga., Dec. 07, 2020 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or “the Company”) announced today that it has completed the previously announced acquisition of Tom George Yacht Group (“TGYG”). TGYG enhances the Company’s presence on the west coast of Florida and expands new and pre-owned boat sales, as well as yacht brokerage and service & parts.“We are excited to have resumed our successful acquisition strategy with the addition of TGYG. Since 2014, we have successfully acquired 40 retail locations. TGYG marks our first since going public in early fiscal year 2020, and is one of the largest acquisitions in our history. We have a strong track record delivering operational synergies and fueling margin expansion by working collaboratively with our dealers, and TGYG will be no different. We look forward...

San Diego, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a preclinical-stage biopharmaceutical company focused on developing proprietary molecules with strong clinical and commercial differentiation, announced today that Punit Dhillon, CEO, Emerald Bioscience will be present a corporate overview at the Benzinga Global Small Cap Virtual Conference taking place on December 8-9, 2020.Presentation details are as follows:Event: Benzinga Global Small Cap Virtual ConferencePresentation Date: Wednesday, December 9, 2020Presentation Time: 12:00 – 12:15 PM ETFor more information and/or to register for the conference please visit: https://events.benzinga.com/registration-pageAbout Emerald Bioscience, Inc.Emerald Bioscience Inc. is a biopharmaceutical company focused on the discovery...

HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter and fiscal year ended September 30, 2020.Fourth Quarter 2020 HighlightsRevenue of $330 million for the fourth quarter of fiscal 2020, an increase of 13% compared with $294 million for the fourth quarter of fiscal 2019Operating income of $14.4 million for the fourth quarter of fiscal 2020, an increase of 4% compared with $13.9 million for the same quarter of fiscal 2019. Operating income for 2020 included a goodwill impairment charge of $7.0 million and executive severance charges of $1.8 millionNet income attributable to IES of $14.6 million, or $0.68 per diluted share, for the fourth quarter of fiscal 2020, compared with $9.9 million, or $0.46 per diluted share, for the same quarter...

BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the subscription period for its previously announced rights offering of shares of the Company’s common stock at a subscription price of $1.07 per share expired on December 4, 2020, and these rights are no longer exercisable.Based on a review of preliminary results provided by the Company’s subscription agent, EQ Shareowner Services, the Company expects to issue approximately 711,143 shares of common stock in the rights offering. The Company expects to receive gross proceeds of approximately $761,000 from the rights offering. The results of the rights offering and the Company’s estimates regarding the gross...